§ BIOTECHNOLOGY
USD · Biotechnology

CDTX

CDTX
USDSector · BiotechnologyMarket cap · $0MBeta · 0.31
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

13F FLOW
217 increased/new, 30 decreased/exited (13F)
AC 13F Analysis

§ 04 · FUNDAMENTALS · THE BOOKS

P/B1.80EPS (TTM)-11.77
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
RA CAPITAL MANAGEMENT, L.P.3.4M7.6%n/a
Vanguard Group1.8M0.0%+63%
HBK INVESTMENTS L P1.3M2.2%n/a
FIL Ltd1.3M0.2%n/a
Darwin Global Management, Ltd.997K4.5%n/a
Vivo Capital, LLC957K13.7%−27%
AC INTELLIGENCE

Top institutional owners for CDTX as of the most recent 13F reporting period (Q4 2025 · Period ended Dec 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER74.0% · 185 holders
PASSIVE / INDEX14.4% · 9 holders
DEALER / BANK10.3% · 18 holders
QUALITY / COMPOUNDER7.3% · 15 holders
TACTICAL / MACRO6.3% · 7 holders
SYSTEMATIC / QUANT3.8% · 5 holders
INCOME / DEFENSIVE0.6% · 14 holders
GROWTH / MOMENTUM0.1% · 1 holder
ACTIVIST0.0% · 1 holder
AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
AC INTELLIGENCE

No Form 4 filings on record for CDTX in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES

No notes mention CDTX yet.